Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 58118-0549
Product NDC
58118-0549- Manufacturer
- Clinical Solutions Wholesale, Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 1, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA209069
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride Dihydrate | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 TABLET in 1 BLISTER PACK (58118-0549-8)
External Resources